home › Reply
-
Lite allmänt om Latisse / BimatoprostQuote:1. J Drugs Dermatol. 2011 Jul 1;10(7):795-8.
Novel treatment of female-pattern androgenetic alopecia with injected bimatoprost 0.03% solution.
Emer JJ, Stevenson ML, Markowitz O.
Mount Sinai School of Medicine, Department of Dermatology, New York, NY.
Female-pattern androgenetic alopecia is a very common disorder that has been associated with extreme psychological morbidity. Few treatments have documented utility and many physicians are often overwhelmed with how little is pharmacologically available to treat this condition. Novel treatments that are effective, safe, less costly and simple are in high demand. We report a case of female-pattern androgenetic alopecia that failed to respond to a novel treatment with injected bimatoprost solution. Hypothetically, the treatment should have been effective and although we did not have success, this report suggests critical points to consider in the future of prostaglandin analogs, as well as other therapies being considered for the treatment of female-pattern hair loss. J Drugs Dermatol. 2011;10(7):795-798.
Närbesläktat:
Stjernschantz J. From PGF2a-isopropyl ester to latanoprost: a review of the development of xalatan: the Proctor Lecture. Invest Ophthalmol Vis Sci 2001;42:1134-1145.